autologous dendritic cells pulsed with antigen peptides
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for autologous dendritic cells pulsed with antigen peptides, covering 2019-12-16 to 2019-12-16. Get the full timeline:
Most recent: Clinical Trial Update: Evaluating Combination Therapy Using Autologous Dendritic Cells Pulsed With Antigen Peptides and Nivolumab for Subjects With Advanced Non-Small Cell Lung Cancer [Phase 1, Phase 2]